VRDN · Viridian Therapeutics, Inc.\DE
Market Cap
$2.60B
Shares
113.29M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1590750
CUSIP
92790C104
13F (30d)
166 filings
166 filers
Visit website
Investor relations